All In Biotech

Free tool

FAERS Monitor: Banzel

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 201367 or its brand name (Banzel, Rufinamide). Reports on generic versions are filed under their own applications.

Reports

2,630

Serious

1,882

72% of reports

Hospitalization

727

Death reported

154

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • seizure670
  • drug ineffective408
  • off label use256
  • somnolence186
  • diarrhoea120
  • condition aggravated116
  • fatigue111
  • vomiting108
  • drug interaction106
  • multiple-drug resistance102
  • generalised tonic-clonic seizure95
  • decreased appetite91
  • fall90
  • hospitalisation88
  • weight decreased87

Reports by year received

View as table
YearReports
20072
20081
200938
201027
201123
201249
201363
201493
2015113
2016130
201797
2018136
2019284
2020237
2021288
2022246
2023161
2024268
2025229
2026145

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,529 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
multiple-drug resistanceSignal102272.0224.126,375
seizureSignal67046.743.729,877
generalised tonic-clonic seizureSignal9546.237.94,133
somnolenceSignal1867.46.41,031
drug interactionSignal1065.34.4373
hospitalisationSignal884.63.7245
decreased appetiteSignal913.12.6132
condition aggravatedSignal1163.12.6160
weight decreasedSignal872.52.077
drug ineffectiveSignal4082.52.3381
off label useSignal2562.32.1203
fallSignal902.21.856
vomiting1081.81.541
diarrhoea1201.51.219
fatigue1111.11.02

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.